alexa Evaluating The Over-time Prognostic Performance Of Biomarkers For Cancer Prognoses Using Time-dependent Receiver Operating Characteristic (ROC) Curve
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Nan Hu
ScientificTracks Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.008
Biomarkers are important tools for early detection of a variety of disease related events, such as disease onset, recurrence, relapse or mortality due to a disease. In this work, I will demonstrate the biostatistical methodology of using sensitivity, specificity, predictive values, and the receiver operating characteristic (ROC) curve to evaluate biomarkers for prognosis of disease related events in a time-dependent fashion by using two examples in cancer studies. At first, I will show the process to assess the prognostic performance of biomarkers with a binary value, such as positive/negative. Under this situation, time- dependent sensitivity, specificity and predictive values were relevant parameters to use. In the first study, the goal of is to evaluate the prognostic accuracies of three pathological biomarkers - estrogen receptor (ER), progesterone receptor (PR), and human epidermal receptor 2 (Her2) - for prognosing breast cancer recurrences over 10 years of follow-up among 2,267 women in California and Utah with a previously diagnosed breast cancer (BC) enrolled in the Lifetime After Cancer Epidemiology (LACE) study. Using data from LACE, we found that Her2 has the best specificity for prognosis of BC recurrences over a 10 years period, but its sensitivity is lower than ER and PR over the same period of time. On the other hand, PR has a much better sensitivity over time than ER and Her2, but a lower specificity than the other two markers. Secondly, I will illustrate the statistical method for evaluating the prognostic performance of a biomarker as a continuous variable through another cancer study of a severe brain tumor, namely oligodendrogliomas. In this study, two continuously measured biomarkers, MIB-1 and MVD, were assessed and compared for their ability to prognose the overall survival and progression free survival for patients with diagnosed oligodendrogliomas of stage II or stage III. Using the time-dependent ROC method, our results indicate that the overall performance of MVD is significantly better than MIB-1. Finally, I will point out that the selection of an appropriate biomarker for disease/mortality prognosis should also be based on the feature of the disease, the type of prognosis (e.g., screening versus confirmative test), and certain economical factors (benefits versus cost).
Nan Hu has completed his Ph.D. in 2010 from Department of Biostatistics at the University of Washington, School of Public Health. He is now an Assistant Professor of Medicine at the University of Utah, and an investigator at Huntsman Cancer Institute. He has published more than 10 papers in reputed Statistics journals and Medical journals and served as Statistics reviewers for Statistic Sinica and several medical journals.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

1-702-714-7001Extn: 9042

General Science

Andrea Jason

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001Extn: 9042

© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version